Insider: Mueller Brian EVP, Chief Financial Officer - BIOMARIN PHARMACEUTICAL INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 72,159 | 0 | 72,159 |
| Value | $3,838,137.21 | $0.00 | $3,838,137.21 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 05/30/2024 | DDS | 5,000 | Direct | COM | $75.19 | $375,950.00 | 72,159 |
| 01/13/2023 | DDS | 2,500 | Direct | COM | $114.50 | $286,250.00 | 27,746 |
| 12/13/2022 | DDS | 2,500 | Direct | COM | $107.50 | $268,750.00 | 27,746 |
| 12/02/2022 | DDS | 1,101 | Direct | COM | $104.50 | $115,054.50 | 27,746 |
| 12/02/2022 | DDS | 2,139 | Direct | COM | $104.50 | $223,525.50 | 27,746 |
| 12/02/2022 | DDS | 3,761 | Direct | COM | $104.50 | $393,024.50 | 27,746 |
| 11/23/2022 | DDS | 934 | Direct | COM | $95.09 | $88,814.06 | 29,792 |
| 11/23/2022 | DDS | 3,500 | Direct | COM | $99.50 | $348,250.00 | 28,847 |
| 11/23/2022 | DDS | 945 | Direct | COM | $99.50 | $94,027.50 | 28,847 |
| 08/05/2022 | DDS | 3,500 | Direct | COM | $94.50 | $330,750.00 | 30,726 |
| 07/08/2022 | DDS | 7,337 | Direct | COM | $89.50 | $656,661.50 | 30,726 |
| 05/04/2022 | DDS | 2,038 | Direct | COM | $84.50 | $172,211.00 | 38,639 |
| 05/04/2022 | DDS | 9,762 | Direct | COM | $84.50 | $824,889.00 | 38,639 |
| 05/07/2021 | DDS | 6,709 | Direct | COM | $79.50 | $533,365.50 | 31,357 |
| 04/05/2019 | DDS | 2,953 | Direct | COM | $94.00 | $277,582.00 | 13,660 |
| 08/07/2018 | DDS | 2,500 | Direct | COM | $104.50 | $261,250.00 | 12,375 |
| 06/22/2018 | DDS | 654 | Direct | COM | $99.50 | $65,073.00 | 12,375 |
| 06/22/2018 | DDS | 2,491 | Direct | COM | $99.50 | $247,854.50 | 12,375 |
| 06/15/2018 | DDS | 2,021 | Direct | COM | $94.50 | $190,984.50 | 13,029 |
| 05/10/2018 | DDS | 2,450 | Direct | COM | $89.50 | $219,275.00 | 15,396 |
| 06/22/2017 | DDS | 2,671 | Direct | COM | $100.00 | $267,100.00 | 12,885 |
| 05/08/2017 | DDS | 2,600 | Direct | COM | $93.17 | $242,242.00 | 13,468 |
| 05/08/2017 | DDS | 4,882 | Direct | COM | $91.17 | $445,091.94 | 13,468 |
| 08/01/2016 | DDS | 287 | Direct | COM | $100.00 | $28,700.00 | 14,260 |
| 12/02/2014 | DDS | 5,000 | Direct | COM | $91.82 | $459,100.00 | 4,593 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research